Ion Channel Drug Discovery

/Tag: Ion Channel Drug Discovery

The Biophysical Society 2019 Satellite Meeting – Drug Discovery for Ion Channels XIX

2018-12-21T10:13:11+00:00

Metrion Biosciences are sponsoring this years' Biophysical Society Satellite event 'Drug Discovery for Ion Channels XIX' in Baltimore on Friday 1st March 2019. Metrion's CSO Dr Marc Rogers and Sales and Marketing Manager Dr Sophie Rose will be attending. Marc Rogers will be presenting "Successful Development of State-dependent Voltage-gated Ion Channel Modulators with in vivo [...]

The Biophysical Society 2019 Satellite Meeting – Drug Discovery for Ion Channels XIX 2018-12-21T10:13:11+00:00

The Biophysical Society 2019 meeting

2018-12-21T10:12:23+00:00

Metrion Biosciences are attending and exhibiting at The 65th Annual meeting of the Biophysical Society in Baltimore, Maryland. Metrion will be exhibiting from Saturday 2nd March to Wednesday 6th March at stand number 348 in the Exhibits hall and the interactive floor plan can be found here. Metrion's CSO Dr Marc Rogers will also be [...]

The Biophysical Society 2019 meeting 2018-12-21T10:12:23+00:00

An Interview with Professor Alistair Mathie

2018-11-26T11:59:46+00:00

Professor Alistair Mathie, one of Metrion's previous external speakers, gives a perspective below regarding his research into two pore domain potassium channels and his involvement in a collaborative project focused on the detection of atrial fibrillation (AF). On the latter topic, Metrion would like to offer its congratulations to Alistair and his colleagues on the Pharmacists [...]

An Interview with Professor Alistair Mathie 2018-11-26T11:59:46+00:00

ELRIG: Pharmaceutical Flow Cytometry and Imaging

2018-10-08T09:07:58+00:00

Sophie Rose will be attending ELRIG: Pharmaceutical Flow Cytometry and Imaging. Please email info@metrionbiosciences.com to schedule a convenient time for a discussion. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities [...]

ELRIG: Pharmaceutical Flow Cytometry and Imaging 2018-10-08T09:07:58+00:00

Ninth Nanion Users Meeting, Munich

2018-10-16T11:14:35+00:00

Metrion Biosciences will be attending the ninth Nanion Technologies User Meeting in Munich, Germany 25-26th October 2018. Metrion's Sam Manyweathers will be presenting:- "Designing multiple assay protocols for ligand-gated ion channel targets using the stacked tip feature on the Patchliner". Nanion feature a dedicated area of their website to collaborative partners and Metrion is delighted to [...]

Ninth Nanion Users Meeting, Munich 2018-10-16T11:14:35+00:00

ELRIG Drug Discovery 2018

2018-10-08T09:03:08+00:00

Sophie Rose and John Ridley will be attending ELRIG Drug Discovery 2018. They will be happy to discuss our range of services with you. Metrion Biosciences will be located at Booth B7 and will also be presenting poster number 64. Our Poster is entitled: "Identification of novel scorpion venom peptide inhibitors of the Kv1.3 ion [...]

ELRIG Drug Discovery 2018 2018-10-08T09:03:08+00:00

Metrion Biosciences strengthens its drug discovery leadership team

2018-09-17T09:49:30+00:00

Metrion Biosciences makes senior appointments to strengthen its drug discovery leadership team Dr Edward Stevens appointed as Head of Drug Discovery, and Dr Andrew Lightfoot as Head of Medicinal Chemistry and Discovery Funding Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has made two senior appointments [...]

Metrion Biosciences strengthens its drug discovery leadership team 2018-09-17T09:49:30+00:00

Metrion Biosciences and AMRI collaborate to offer ion channel drug discovery services

2018-09-10T14:38:27+00:00

Metrion Biosciences and AMRI collaborate to offer ion channel drug discovery services Agreement enables customers to access a broader range of drug discovery expertise. Metrion Biosciences Limited (“Metrion”), the specialist ion channel CRO and drug discovery company, and AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve [...]

Metrion Biosciences and AMRI collaborate to offer ion channel drug discovery services 2018-09-10T14:38:27+00:00

An interview with Professor Mustafa Djamgoz

2018-07-31T11:05:00+00:00

 Professor Mustafa Djamgoz (Imperial College London), the sixth presenter in Metrion Biosciences External Speaker Series, provides some insight into his research into the role of ion channels in cancer and metastasis. You first published observation regarding the upregulation of voltage-gated sodium channels (VGSCs) in cancer cell lines in 1995. What was your initial rationale for [...]

An interview with Professor Mustafa Djamgoz 2018-07-31T11:05:00+00:00

An interview with Professor Annette Dolphin

2018-07-23T15:13:16+00:00

Professor Annette Dolphin (University College London), Metrion Biosciences Scientific Advisory Board member and the seventh presenter in Metrion Biosciences External Speaker Series, gives a perspective on her research into  neuronal voltage-dependent calcium channels. How and when did you first become interested in neuropharmacology? In the second year of my Biochemistry degree in Oxford, during my Diploma [...]

An interview with Professor Annette Dolphin 2018-07-23T15:13:16+00:00